Pages
- Home
- About us
- Clinical Advisors
- Our team
- Scientific Advisory Board
- Our Science
- Portfolio
- Pipeline
- Publications
- Netrin-1 Lead Program
- News
- Careers
- Contact us
- Mentions légales
- Sitemap Page
Articles par catégorie
- Catégorie : Actualités
- NETRIS Pharma selected by the European Innovation Council Accelerator among the most innovative startups and SMEs companies in Europe !
- Check out NETRIS Pharma during TEMTIA 9.5 virtual meeting, starting December 14th !
- ESMO Congress – 2021
- NETRIS Pharma Announces First Patient Dosed in Phase Ib/II
- Bio Partnering @ JPM – January 2021
- NETRIS Pharma successfully completes a €16.1m Series A
- Press release – Clinical Trial Collaboration Agreement with MSD (Merck US)
- NETRIS Pharma welcomes its new CMO
- BIO-Europe – Hamburg , 2019
- ESMO Congress – Barcelona, 2019
- ANR granted the RHU DEPGYN project
- Colloque Cancers de la Femme – Paris, 2019
- Annual J.P. Morgan Healthcare Conference – San Francisco, 2019
- Press release – Completion of NP137 Dose-Escalation Phase 1 trial
- BIO International Convention – Boston, 2018
- Presentation at PEGS – Boston, 2018
- BIO-Europe Spring – Amsterdam, 2018
- Pr. Bernet appointed as Knight of the Legion of Honor
- Annual J.P. Morgan Healthcare Conference – San Francisco, 2018
- Press release – Start of NP137 Phase I clinical trial
- Catégorie : Event
- Catégorie : News